ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products

Reviewed

From ACROBiosystemsMar 7 2019

ACROBiosystems, a leading manufacturer of recombinant proteins, announced that they have signed a collaboration agreement with ProMab Biotechnologies, a leading manufacturer of monoclonal antibodies and CAR-T cells.

The combination of ACROBiosystems protein portfolio, innovation lab capabilities and ProMab’s distinct experience in antibody and CAR-T cell generation, together our companies can bring added value and support to cancer immunotherapy development”.

Mike Chen, CEO of ACROBiosystems

These two biotech companies have been producing innovative products and custom services in the life Bio Pharmaceutical Industry for decades.

It is exciting to formalize a collaboration with a company whom we respect and whose innovative services complement our own so well”.

John Wu, CEO of ProMab Biotechnologies

It is expected that the services offered through this collaboration will become available in either company’s websites in the next few weeks.

Source:

https://www.acrobiosystems.com/A1082-ACROBiosystems-Announces-Collaboration-with-ProMab-Biotechnologies-for-Immunotherapy-Research.html

Posted in: Life Sciences News

Tags: Antibodies, Antibody, B Cell, Cancer, Cancer Immunotherapy, CAR T-cell, Cell, Chimeric Antigen Receptor, Immunotherapy, Protein, Research, T-Cell

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
ACROBiosystems. (2019, June 24). ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx.
MLA
ACROBiosystems. "ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx>.
Chicago
ACROBiosystems. "ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products". News-Medical. https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx. (accessed November 21, 2024).
Harvard
ACROBiosystems. 2019. ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx.